$3.32
▼ -0.9% Today
as of Aug 5, 16:47 ET
Last 30 days
Recent Press Releases & News
CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer
CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
Overview
52-week range
$1.72
$8.21
25% of range
Avg surprise (last 3)
+59.5%
Avg reaction (last 2)
+63.2%
50% positive
Latest IV / EM
197%
EM ±32.8% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.10 | $-0.14 | +28.6% | -137.0% | -3.1% | earnings |
| Thu Aug 7, 2025 | Jun/2025 | — | $-0.06 | +100.0% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $0.27 | $0.18 | +50.0% | — | +129.5% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | AMC | -$0.11 | — |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | — | $6M | $19M | $51M | — | $33M | $25M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-20M | — | $-16M | $-1M | $23M | — | $4M | $-8M |
| Net income | $-18M | — | $-14M | $-154,000 | $24M | — | $6M | $-7M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $29M | $13M | $34M | $49M | $48M | $38M | $41M | $43M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $353M | $144M | $149M | $165M | $87M | $107M | $124M | $143M |
| Total assets | $359M | $152M | $158M | $175M | $98M | $121M | $139M | $159M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $39M | $53M | $51M | $55M | $73M | $121M | $162M | $190M |
| Total equity | $320M | $99M | $107M | $120M | $25M | $-456,000 | $-23M | $-31M |